Matthew Maciejewski

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Area:
Public Health
Google:
"Matthew Maciejewski"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rosland AM, Wong E, Maciejewski M, et al. (2017) Patient-Centered Medical Home Implementation and Improved Chronic Disease Quality: A Longitudinal Observational Study. Health Services Research
Lee JL, Maciejewski M, Raju S, et al. (2013) Value-based insurance design: quality improvement but no cost savings. Health Affairs (Project Hope). 32: 1251-7
Johnson MR, Grubber JM, Grambow S, et al. (2013) Mo1103 Physician and Patient Factors As Potential Predictors of Non-Adherence to Colonoscopy Guidelines in an Integrated Managed Care System Gastroenterology. 144: S-578-S-579
Hansen RA, Maciejewski M, Yu-Isenberg K, et al. (2012) Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. Psychiatric Services (Washington, D.C.). 63: 920-8
Shah T, Grubber JM, Grambow S, et al. (2012) Sa1137 Adequacy of Bowel Preparation and Documentation of Bowel Preparation Quality at Index Colonoscopy in the VA Health Care System Gastroenterology. 142: S-225-S-226
Fisher DA, Grubber JM, Grambow S, et al. (2012) 344 Factors Associated With Non-Adherence to Colonoscopy Interval Guidelines in an Integrated Managed Care System Gastroenterology. 142: S-80
Kennedy JJ, Maciejewski M, Liu D, et al. (2011) Cost-related nonadherence in the Medicare program: the impact of Part D. Medical Care. 49: 522-526
Farley J, Hansen R, Yu-Isenberg K, et al. (2011) PMH46 THE EFFECT OF ANTIPSYCHOTIC ADHERENCE ON ADHERENCE TO DIABETES, HYPERLIPIDEMIA, AND HYPERTENSION MEDICATIONS AND ASSOCIATED HEALTH SERVICE UTILIZATION Value in Health. 14: A194
Hansen RA, Farley JF, Droege M, et al. (2010) A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clinical Therapeutics. 32: 1308-19
Prela CM, Baumgardner GA, Reiber GE, et al. (2009) Challenges in merging Medicaid and Medicare databases to obtain healthcare costs for dual-eligible beneficiaries: using diabetes as an example. Pharmacoeconomics. 27: 167-77
See more...